# Oxytocin Treatment of Schizophrenia

> **NCT01028677** · NA · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 17 (actual)

## Conditions studied

- Paranoia
- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** intranasal spray with oxytocin
- **OTHER:** nasal spray without oxytocin

## Key facts

- **NCT ID:** NCT01028677
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2017-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01028677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01028677, "Oxytocin Treatment of Schizophrenia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01028677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*